Janssen Pharmaceuticals
Janssen Pharmaceuticals is a subsidiary of Johnson & Johnson with headquarters in Beerse, Belgium.
In 1961, the New Jersey-based American company JohnRead more...
- Eprex 4000IU 0.4 ml InjectionRecombinant Human Erythropoietin Alfa / Epoetin Alfa1 Injection/s : $32.64As low as $68.25
- Eprex 10000 IU 1ml InjectionRecombinant Human Erythropoietin Alfa / Epoetin Alfa1 Injection/s : $82.44As low as $172.50
- Eprex 40000 IU InjectionRecombinant Human Erythropoietin Alfa / Epoetin Alfa1 Injection/s : $246.17As low as $516.38
- Eprex 1000 IU 0.5 ml InjectionRecombinant Human Erythropoietin Alfa / Epoetin Alfa1 Injection/s : $9.06As low as $28.69
Janssen Pharmaceuticals is a subsidiary of Johnson & Johnson with headquarters in Beerse, Belgium.
In 1961, the New Jersey-based American company Johnson & Johnson acquired Janssen Pharmaceuticals. Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now known as Janssen Research and Development (JRD), conducts research and development on a variety of human medical conditions, including mental illness, HIV/AIDS, neurological disorders, anesthesia and analgesia, gastrointestinal disorders, and fungal infections,